版本:
中国

BRIEF-SciClone Pharmaceuticals to be acquired by Consortium Led by GL Capital

June 8 Sciclone Pharmaceuticals Inc

* Sciclone Pharmaceuticals Inc says deal for $11.18 per share Sciclone enters into definitive merger agreement to be acquired by consortium led by GL capital

* Sciclone pharmaceuticals inc says deal for ‍approximately $605 million​

* Transaction, which was unanimously approved by Sciclone's board, values company at approximately $605 million

* Transaction will be funded by buyer consortium through a combination of equity financing

* Says lazard is serving as exclusive financial advisor to Sciclone and Dla Piper LLP (us) is serving as its legal advisor

* Transaction was unanimously approved by Sciclone's board

* Transaction will also be funded by consortium through debt financing, and is not subject to a financing condition Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐